Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-3-30
pubmed:abstractText
The present study compared the extent and duration of MAO inhibition by the selective and reversible MAO-A inhibitor brofaromine with the selective and irreversible MAO-A inhibitor clorgyline using amine pressor tests and excretion of urinary amine metabolites (MHPG, tryptamine). The pharmacological characterization of clorgyline as an irreversible and brofaromine as a reversible MAO-A inhibitor in clinically effective doses was confirmed in humans.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-9564
pubmed:author
pubmed:issnType
Print
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:7865179-Administration, Oral, pubmed-meshheading:7865179-Adult, pubmed-meshheading:7865179-Blood Pressure, pubmed-meshheading:7865179-Clorgyline, pubmed-meshheading:7865179-Cross-Over Studies, pubmed-meshheading:7865179-Dose-Response Relationship, Drug, pubmed-meshheading:7865179-Drug Synergism, pubmed-meshheading:7865179-Female, pubmed-meshheading:7865179-Humans, pubmed-meshheading:7865179-Hypertension, pubmed-meshheading:7865179-Infusions, Intravenous, pubmed-meshheading:7865179-Male, pubmed-meshheading:7865179-Methoxyhydroxyphenylglycol, pubmed-meshheading:7865179-Monoamine Oxidase, pubmed-meshheading:7865179-Norepinephrine, pubmed-meshheading:7865179-Piperidines, pubmed-meshheading:7865179-Reference Values, pubmed-meshheading:7865179-Tryptamines, pubmed-meshheading:7865179-Tyramine
pubmed:year
1994
pubmed:articleTitle
Monoamine oxidase inhibition by the MAO-A inhibitors brofaromine and clorgyline in healthy volunteers.
pubmed:affiliation
Human Pharmacology Institute, Ciba-Geigy GmbH, Tübingen, Federal Republic of Germany.
pubmed:publicationType
Journal Article